Gabapentin preoperative use for evaluation of benefit to reduce pain during and after
      surgical office-based abortion.

Gabapentin for Perioperative Pain Relief in Surgical Abortion

Pain Control

A double-blind placebo controlled trial of gabapentin in the setting of an ambulatory
      surgical abortion center where patients receive either the routine intravenous sedation,
      local cervical anesthesia plus 600mg of gabapentin one hour prior to surgery vs. the same
      regimen plus placebo one hour prior to surgery. Our primary outcome measure will be
      post-operative validated pain scores using a 11-point visual analog scale (VAS). Secondary
      measures will include nausea and vomiting during, after and 24 hours after the procedure. A
      second and third pain assessment using VAS will be made at 30 minutes and at 24 hours
      postoperatively.

Gabapentin

Placebos

Gabapentin for Perioperative Pain Relief in Surgical Abortion: a Double-blind Randomized Controlled Trial

100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain

Associate Professor, OB/GYN

Pain at 24 hours postoperative on 100mm VAS, 1=no pain, 100=extreme pain

Nausea at 24 hours using 100mm VAS, 1=none, 100=extreme

Vomiting at 24 hrs, 100mm VAS, 1=none, 100=extreme

100mm Visual analog scale for level of pain, 1-100, 1=no pain, 100= extreme pain

Gabapentin 600 mg given 1-2 hours prior to surgical abortion

Placebo (vit C) given 1-2 hours prior to surgical abortion

Gabapentin for Perioperative Pain Relief in Surgical Abortion

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status